Levamisole Impurity 1 | CAS 17899-33-1 - Request Quote
Levamisole Impurity 1
| SZ CAT No: | SZ-L075008 |
| CAS No | 17899-33-1 |
| Mol.F. | C11H14N2OS : HCl |
| Mol.Wt. | 222.3 : 36.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 10060-88-5 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Levamisole Impurity 1 is chemically 2-(2-Iminothiazolidin-3-yl)-1-phenylethan-1-ol hydrochloride. Levamisole Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Levamisole Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Levamisole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 17899-33-1
Purchase 17899-33-1
Order 17899-33-1
Enquire 17899-33-1
price of 17899-33-1
17899-33-1 Supplier
17899-33-1 Manufacturer
17899-33-1 Exporter
buy high quality Levamisole Impurity 1
Purchase Levamisole Impurity 1
Levamisole Impurity 1 suppliers
Levamisole Impurity 1 manufacturers
Levamisole Impurity 1 price
Order Levamisole Impurity 1
Enquire Levamisole Impurity 1
Levamisole Impurity 1 cost
Levamisole Impurity 1 Supplier
Levamisole Impurity 1 Distributor
Levamisole Impurity 1 for Method Validation
Levamisole Reference Standard
Levamisole Impurity 1 for ANDA Filing
Levamisole Impurity 1 for Forced Degradation Studies
Levamisole Impurity 1 Identification Standards
Levamisole Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.